Wednesday, July 8, 2026

biotech · Glioblastoma · Recurrent Brain Metastases · GTBP

GT Biopharma

GT Biopharma patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Brisbane, USA HQ
1973 Founded
8 Employees
Public company Type
GTBP · NYSE Ticker
Company details
Status
Public
HQ
Brisbane, USA
Founded
1973
Employees
8
Programs
8
Drugs
7
Patents
1
Intelligence · Patents

GT Biopharma patents

1 pharmaceutical patents indexed for GT Biopharma. 0 expire within 24 months.

GT Biopharma has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 10071150

    Immunity enhancing therapeutic vaccine for HPV and related diseases

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does GT Biopharma have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do GT Biopharma patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.